CASP3 and melanoma: We also analysed in the same experimental settings cleaved caspase-3/7 contents and we confirmed that interfering on BAG3 protein expression sensitizes to apoptosis melanoma cells subjected to a prolonged treatment with Vemurafenib (Figure 2B).